Inspire Medical Systems, Inc. maintained revenue guidance for the full year 2024. For the period, the company maintained revenue guidance of between $775 million to $785 million, which represents growth of 24% to 26% over full year 2023 revenue of $624.8 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
167.8 USD | -3.75% | -32.79% | -17.50% |
May. 08 | Top Premarket Decliners | MT |
May. 07 | Transcript : Inspire Medical Systems, Inc., Q1 2024 Earnings Call, May 07, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.50% | 4.99B | |
+10.39% | 126B | |
-6.86% | 10.96B | |
+2.52% | 8.97B | |
+38.96% | 5.56B | |
+8.36% | 3.44B | |
-8.84% | 2.8B | |
-7.52% | 2.18B | |
-3.00% | 2.16B | |
-21.88% | 1.82B |
- Stock Market
- Equities
- INSP Stock
- News Inspire Medical Systems, Inc.
- Inspire Medical Systems, Inc. Reaffirms Revenue Guidance for the Full Year 2024